journal
https://read.qxmd.com/read/39344020/clinical-efficacy-and-mechanistic-insights-of-anshen-dingzhi-prescription-on-breast-cancer-related-ptsd-through-network-pharmacology-and-molecular-docking
#1
JOURNAL ARTICLE
Hao Zhang, Yongfu Zhu, Guoqi Zhu, Shaojie Yang
Anshen Dingzhi prescription (ADP) is a classic prescription of traditional Chinese medicine, which has been used in the treatment of neuropsychiatric diseases. However, its treatment of breast cancer-related post-traumatic stress disorder (BC-PTSD) lacks clinical research evidence and its mechanism is not clear. The present study investigated the efficacy and action mechanism of ADP against BC-PTSD. The results of the clinical trial showed that after 4 weeks of treatment, both groups showed reduced post-traumatic stress disorder checklist-civilian version (PCL-C), Pittsburgh sleep quality index (PSQI), self-rating depression scale (SDS) and self-rating anxiety scale (SAS) scores, and increased functional assessment of cancer therapy-breast (FACT-B) scores...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39313964/conventional-therapy-combined-with-quxie-capsule-modulating-gut-microbiome-in-metastatic-colorectal-cancer-patients-with-the-third-or-above-line-setting-result-from-an-investigator-initiated-open-label-single-arm-phase-ii-study
#2
JOURNAL ARTICLE
Zhien Gu, Lei Wang, Jiawei Zhai Ma, Tong Zhang, Yufei Yang
BACKGROUND: In patients with metastatic colorectal cancer (mCRC), Quxie Cap-sule (QX)-a combination of conventional therapy (including chemotherapy, targeted therapy or supportive care)-has shown a significant overall survival benefit compared with placebo and might have the property of dual effects of antitumor and immunity enhancement, both mediated by the microbiome. In preclinical models, QX has also shown activity against colorectal cancer. This study aimed to describe how the aforementioned effects of QX look after when focusing on the patients in third or above line setting...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39305200/the-effectiveness-of-immersive-virtual-reality-as-a-complementary-approach-and-a-new-direction-in-cancer-related-fatigue-management
#3
JOURNAL ARTICLE
Bushra Alhusamiah, Mohannad Aldiqs, Ruqayya S Zeilani
Background: Recent advancements in the field of medical technology have illuminated that the implementation of virtual reality interventions can be highly effective in managing cancer-related fatigue. Moreover, this innovative intervention has demonstrated a substantial improvement in patients' overall well-being and daily functioning. Thus, it represents a promising alternative to traditional pharmacological treatments by effectively addressing symptoms and enhancing quality of life. Therefore, the integration of this approach signifies a significant advancement in patient care...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39300870/a-basis-for-strengthening-coping-strategies-and-treatment-expectations-in-patients-undergoing-emetogenic-pelvic-abdominal-radiotherapy-a-longitudinal-study
#4
JOURNAL ARTICLE
Anna Efverman, Marja-Leena Kristofferzon
Objectives: To study the relationship between coping strategies and nausea during emetogenic pelvic-abdominal radiotherapy, and to describe the patients' rationales for their expectations regarding nausea. Methods: Patients (n = 200: 84% women, mean age 64 years, 69% had gynecological, 27% colorectal, and 4% had other malignances) longitudinally participated during pelvic-abdominal radiotherapy. We measured adopted coping strategies using the Mental Adjustment to Cancer scale and the patients' rationales for their expectations regarding nausea at baseline...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39256983/inhibition-of-myeloma-cell-function-by-cannabinoid-enriched-product-associated-with-regulation-of-telomere-and-tp53
#5
JOURNAL ARTICLE
Ibrahim Musa, Nan Yang, Joseph Breslin, Orion Paulden, Jan Geliebter, Raj Tiwari, Xiu-Min Li
Multiple myeloma is a hematological cancer caused by the uncontrolled proliferation of abnormal plasma cells in the bone marrow, leading to excessive immunoglobulin production. Our study aimed to examine the anticancer properties of BRF1A, a cannabinoid (CBD)-enriched product, on 2 myeloma cell lines: U266 and ARH-7. We treated U266 and ARH-77 myeloma cells with varying doses of BRF1A and measured the production of IgE and IgG antibodies using ELISA. Cell viability was assessed using trypan blue and CCK-8 assays...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39256982/effectiveness-of-the-traditional-japanese-medicine-goshajinkigan-in-preventing-paclitaxel-induced-peripheral-neuropathy-a-multicenter-randomized-comparative-trial
#6
RANDOMIZED CONTROLLED TRIAL
Yukiko Matsumura, Masayuki Futagami, Tsukasa Baba, Shu Soeda, Hidemichi Watari, Yukihiro Terada, Hideki Tokunaga, Satoru Nagase, Toru Nakanishi, Michiko Kaiho, Yoshihito Yokoyama
Objective: Development of chemotherapy-induced peripheral neuropathy (CIPN) poses significant challenges in cancer treatment, often leading to dose reductions or treatment discontinuation. Goshajinkigan (GJG), a traditional Japanese medicine, has shown promise for alleviating CIPN symptoms. This multicenter, randomized controlled trial aimed to prospectively examine the efficacy of GJG in preventing paclitaxel-induced peripheral neuropathy. Methods : This study enrolled 55 patients with ovarian cancer undergoing first-line chemotherapy using paclitaxel and carboplatin...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39223848/harnessing-hyperthermia-molecular-cellular-and-immunological-insights-for-enhanced-anticancer-therapies-comment
#7
LETTER
Hinpetch Daungsupawong, Viroj Wiwanitkit
No abstract text is available yet for this article.
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39223822/chinese-herbal-compound-xiaoliu-pingyi-recipe-inhibits-the-growth-of-lung-adenocarcinoma-by-regulating-the-tumor-vascular-microenvironment
#8
JOURNAL ARTICLE
Fei-Ran Yang, Hong-Lin Li, Xi-Wen Hu, Rong Fu, Xiu-Rong Li, Hui-Jie Li
BACKGROUND: The traditional Chinese medicine (TCM) Xiaoliu Pingyi recipe (XLPYR) has been clinically used for several decades, demonstrating favorable therapeutic effects. However, the underlying regulatory mechanisms remain unclear. The aim of this study was to explore the anti-tumor effects of XLPYR and its regulatory role in the vascular microenvironment through in vivo and in vitro experiment. MATERIALS AND METHODS: In the in vivo study, a C57BL/6J mouse model of lung adenocarcinoma (LUAD) allografts was established, and various interventions were administered for 14 days (Model group: administered normal saline via oral gavage; Pemetrexed (PEM) group: intraperitoneally injected with a solution of pemetrexed, once every 3d; XLPYR group: administered XLPYR via oral gavage; Combination (COMBI) group: received XLPYR via oral gavage simultaneously with intraperitoneal injection of pemetrexed solution)...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39223798/targeting-the-gut-microbiome-to-improve-immunotherapy-outcomes-a-review
#9
REVIEW
Adi David, Shaked Lev-Ari
The following narrative review embarks on a comprehensive exploration of the role played by the gut microbiome within the Diet-Microbiota-Immunity (DMI) tripartite, aiming to enhance anti-cancer immunotherapy efficacy. While revolutionizing cancer treatment, resistance to immunotherapy and immune-related adverse events (irAEs) remain challenges. The tumor microenvironment (TME), shaped by cancer cells, influences immunotherapy resistance. The gut microbiome, influenced by genetics, environment, diet, and interventions, emerges as a critical player in TME reshaping, thereby modulating immune responses and treatment outcomes...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39223789/comparison-of-effects-between-telerehabilitation-and-in-person-rehabilitation-after-breast-cancer-surgery-a-randomized-controlled-study
#10
RANDOMIZED CONTROLLED TRIAL
Leonardo Breno do Nascimento de Aviz, Camila Ferreira Alves, Carolina Lima da Fonte, Lorena de Nazaré Rocha Corrêa, Raphaely Cristiny Sanches Progênio, Laerte Jonatas Leray Guedes, Laura Maria Tomazi Neves, Saul Rassy Carneiro
OBJECTIVE: To compare the effects between telerehabilitation and in-person rehabilitation on physical function, pain and quality of life in patients with breast cancer after surgery. DESIGN: Randomized, controlled, and parallel study that involved post-surgical oncological breast surgery patients who were female and aged between 18 and 70 years. The study was conducted in an outpatient environment, and the participants were randomized using a computer system...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39199013/omega-3-fatty-acids-increase-weight-and-quality-of-life-scores-in-patients-with-advanced-non-small-cell-lung-cancer-and-cancer-cachexia-a-meta-analysis
#11
REVIEW
Alfredo V Chua, Aylmer Rex B Hernandez, Marvin Jonne L Mendoza, Michael D San Juan
BACKGROUND: Cancer cachexia is a common debilitating weight loss syndrome in advanced cancer, particularly lung cancer. Omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid, with their immune-modulating effects, have been used to improve the nutritional status of patients with cancer cachexia. AIM: Evaluate the effects of omega-3 fatty acids in change in weight and lean body/skeletal mass, and health-related quality of life scores (HRQoL) in patients with advanced non-small cell lung cancer and cancer cachexia...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39189615/transcriptomics-reveals-the-mechanism-of-platycodin-d-targeting-tgf%C3%AE-for-anti-lung-cancer-activity
#12
JOURNAL ARTICLE
Mei Feng, Xue Jing Wang, Yi Liu, Wei Zhang, Ying Wang, Chuchu Zhang, Shengchuan Bao
Lung cancer is the most prevalent and lethal malignant tumor in China, primarily categorized into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC accounts for more than 80% of all lung cancer cases, with current treatments primarily consisting of surgery, chemotherapy, and targeted therapy. However, these treatments often come with various adverse effects and drug resistance issues, highlighting the urgent need for new NSCLC therapies. Traditional Chinese medicine serves as a natural treasury of medicinal compounds and an important avenue for discovering novel active compounds...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39164885/a-single-item-expectancy-measure-s-validity-reliability-and-responsiveness-to-detect-changes-in-clinical-efficacy-studies-of-integrative-cancer-therapies-a-methodology-study
#13
JOURNAL ARTICLE
Anna Efverman
BACKGROUND: Expectations may modify outcomes. However, studies often fail to measure expectations. This raises the need for a brief valid and reliable expectancy measure. OBJECTIVES: To study treatment expectations in individuals entering acupuncture or rest, validity and test re-test reliability of a single-item expectancy measure graded on a category scale, a Numeric Rating Scale (NRS) and a Visual Analog Scale (VAS), and to identify psychometric differences between the scales...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39155547/interdisciplinary-integrative-oncology-group-based-program-evaluation-of-long-term-effects-on-resilience-and-use-of-complementary-and-alternative-medicine-in-patients-with-cancer
#14
JOURNAL ARTICLE
Marek Jonas Von Reusner, Bettina Märtens, Stephanie Barthel, Axel Weiser, Yvonne Ziert, Diana Steinmann, Burcu Babadağ-Savaş
BACKGROUND: Cancer often causes reduced resilience, quality of life (QoL) and poorer overall well-being. To mitigate these problems, complementary and alternative medicine (CAM) is widely used among patients with cancer. This study aimed to evaluate the long-term effects of an interdisciplinary integrative oncology group-based program (IO-GP) on the resilience and use of CAM in patients with cancer. METHODS: This was a prospective, observational, single-center study...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39155544/jianpi-jiedu-recipe-inhibits-proliferation-through-reactive-oxygen-species-induced-incomplete-autophagy-and-reduces-pd-l1-expression-in-colon-cancer
#15
JOURNAL ARTICLE
Lingling Cheng, Liangfeng Xu, Hua Yuan, Qihao Zhao, Wei Yue, Shuang Ma, Xiaojing Wu, Dandan Gu, Yurong Sun, Haifeng Shi, Jianlin Xu
BACKGROUND: Jianpi Jiedu Recipe has been used to treat digestive tract tumors in China since ancient times, and its reliability has been proven by clinical research. Currently, the specific biological mechanism of JPJDR in treating tumors is unclear. METHODOLOGY: CCK-8 assay was used to detect cell viability. Clone formation assay and EdU assay were used to detect cell proliferation potential. DCFH-DA probe and JC-1 probe were used to detect total intracellular reactive oxygen species and mitochondrial membrane potential, respectively...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39135426/music-therapy-and-music-intervention-for-nsclc-patients-undergoing-pet-with-fear-of-cancer-recurrence
#16
RANDOMIZED CONTROLLED TRIAL
Yi-Jie Du, Yi-Hui Guan, Kevin T Thome, Jing-Cheng Dong
Background: Cancer and psychiatric symptoms are associated. Fear of cancer recurrence (FCR) is the most common psychological problem for cancer survivors. Pharmacological interventions can help, but also have major drawbacks. Music therapy and music interventions have been shown to be a safe and practical complementary treatment. Objective: This randomized, controlled trial aimed to investigate the effects of music therapy and music intervention in attenuating non-small cell lung cancer (NSCLC) patients' anxiety related to FCR...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39103991/a-randomized-multi-center-open-label-study-to-compare-the-safety-and-efficacy-between-afatinib-monotherapy-and-combination-therapy-with-had-b1-for-the-locally-advanced-or-metastatic-nsclc-patients-with-egfr-mutations
#17
RANDOMIZED CONTROLLED TRIAL
Eunbin Kwag, Soo-Dam Kim, Seong-Hoon Shin, Chulho Oak, So-Jung Park, Jun-Yong Choi, Seong Hoon Yoon, In-Cheol Kang, Mi-Kyung Jeong, Hyun Woo Lee, Sun-Hwi Bang, Ji Woong Son, Sanghun Lee, Seung Joon Kim, Hwa-Seung Yoo
BACKGROUND: Lung cancer, especially non-small cell lung cancer (NSCLC), poses a significant health challenge globally due to its high mortality. Afatinib, a second-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), has shown superior efficacy over traditional chemotherapy in NSCLC treatment. However, issues like secondary resistance and adverse effects call for alternative therapies. HAD-B1, comprising 4 herbal medicines, has shown promise in lung cancer treatment in both preclinical and clinical settings...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39081223/hypothesis-proteolytic-proenzymes-have-a-role-in-the-ornish-program-for-prostate-cancer
#18
LETTER
Linda L Isaacs
No abstract text is available yet for this article.
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39081216/oral-decoctions-based-on-qi-yin-syndrome-differentiation-after-adjuvant-chemotherapy-in-resected-stage-%C3%AE-%C3%AE-%C3%AE-a-non-small-cell-lung-cancer-a-randomized-controlled-trial
#19
RANDOMIZED CONTROLLED TRIAL
Yi Jiang, Fang-Fang Liu, Yu-Qing Cai, Peng Zhang, Xiao-Feng Yang, Xiang-Yan Bi, Ruo-Yan Qin, Shi Zhang, Ju-Hua Yin, Li-Ping Shen, Jia-Xiang Liu, Ling-Shuang Liu
OBJECTIVE: Powerful adjuvant strategies are required to improve the survival of patients with completely resected stage ΙΙΙA non-small cell lung cancer (NSCLC). We aimed to compare the efficacy of traditional Chinese medicine (TCM) treatment versus observation after adjuvant chemotherapy in these patients. METHODS: Eligible patients were randomized 1:1 to receive either oral decoctions based on Qi-Yin syndrome differentiation (TCM group) or observation (observation group)...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/39077786/effects-of-jianpi-huayu-decoction-on-th1-th2-immune-balance-in-mice-with-liver-cancer-related-fatigue-via-the-il-27-stat1-signaling-pathway
#20
JOURNAL ARTICLE
Chen Jiayi, Chen Siru, Luo Xiaoqi, Xu Enling, Wu Hui, Lin Juze, Wang Changjun
Objective: The Chinese medicine Jianpi-Huayu decoction (, JPHY) can alleviate cancer-related fatigue in patients with liver cancer. However, its mechanism remains unclear. In this study, we used BALB/c mice with liver cancer model to investigate whether JPHY alleviates cancer-related fatigue by regulating Th1/Th2 immune balance; and the possible association with the IL-27/STAT1 signaling pathway. Methods: We established a mouse model of liver cancer fatigue. Mice were gavaged with physiological saline, low, medium, or high concentrations of JPHY respectively; and intraperitoneal injection of fludarabine (STAT1 pathway inhibitor) with JPHY for 21 days...
2024: Integrative Cancer Therapies
journal
journal
39869
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.